Lower GI: Colorectal molecular markers (MMR/MSI)
Free question published 10 November 2026
A 47-year-old woman presents with newly diagnosed, previously untreated metastatic colorectal cancer. Tumour testing shows mismatch-repair deficiency with high microsatellite instability (dMMR/MSI-high). She is fit for systemic therapy. What is the most appropriate first-line systemic treatment?
- AFOLFIRI plus cetuximab
- BEncorafenib plus cetuximab
- CPembrolizumab monotherapy
- DSingle-agent capecitabine
- EFOLFOX plus bevacizumab
Why C is correct
KEYNOTE-177 showed that first-line pembrolizumab was superior to chemotherapy in MSI-high/dMMR metastatic colorectal cancer, with a median progression-free survival of 16.5 versus 8.2 months (HR 0.60, P=0.0002) and far less grade 3 or higher toxicity. Pembrolizumab monotherapy is the preferred first-line option for this molecular subgroup.
And why the others are not
- AIncorrect. Anti-EGFR therapy depends on RAS status and is not the first choice in MSI-high disease where immunotherapy is superior.
- BIncorrect. Encorafenib plus cetuximab is for BRAF V600E-mutant disease, not selected by MMR/MSI status.
- DIncorrect. Single-agent capecitabine is inadequate for a fit patient with metastatic disease and ignores the MSI-high indication for immunotherapy.
- EIncorrect. Chemotherapy plus bevacizumab is the comparator that pembrolizumab outperformed in this molecular subgroup.
Source KEYNOTE-177 — first-line pembrolizumab versus chemotherapy in MSI-high/dMMR metastatic colorectal cancer — Andre T, Shiu KK, Kim TW, et al. Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer (KEYNOTE-177). N Engl J Med. 2020;383:2207-2218.
More free lower gi questions
- Lower GI: Colon adjuvant chemotherapy duration (IDEA) · 30 October 2026
- Lower GI: Total neoadjuvant therapy (PRODIGE-23) · 19 October 2026
- Lower GI: Rectal MRI risk stratification and neoadjuvant selection · 08 October 2026
Sitting in February? Follow the twenty-week plan.
2,500+ cited questions like this one are waiting in the vault.
See plans and pricing